First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
In workers’ compensation, one of the most effective ways to reduce claim duration and associated costs is to get injured employees back to work—saf
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in
When a workplace injury disrupts an employee’s ability to work, the path back to productivity can be complex.
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp.